Publications by authors named "Alan S Coates"

Claim this Profile
P
Prognostic value of patient-reported depression in women with hormone-responsive early breast cancer in TEXT and SOFT.
Karin Ribi, Bernard F Cole, Gini F Fleming, Barbara A Walley, Prudence A Francis, Alan S Coates

Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Characterization and Prognostic Significance of Human Epidermal Growth Factor Receptor 2-Low, Hormone Receptor-Positive, Early Breast Cancers From the BIG 1-98 and SOFT Clinical Trials.
Stephen J Luen, Lauren C Brown, Courtney T van Geelen, Peter Savas, Roswitha Kammler, Alan S Coates

JCO Precis Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
Prudence A Francis, Gini F Fleming, István Láng, Eva M Ciruelos, Hervé R Bonnefoi, Alan S Coates

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.
Olivia Pagani, Barbara A Walley, Gini F Fleming, Marco Colleoni, István Láng, Alan S Coates

J Clin Oncol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Jose P Leone, Bernard F Cole, Meredith M Regan, Beat Thürlimann, Alan S Coates

Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
Manuela Rabaglio, Zhuoxin Sun, Rudolf Maibach, Anita Giobbie-Hurder, Bent Ejlertsen, Alan S Coates

Breast Cancer Res Treat· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment-induced symptoms, depression and age as predictors of sexual problems in premenopausal women with early breast cancer receiving adjuvant endocrine therapy.
Karin Ribi, Weixiu Luo, Barbara A Walley, Harold J Burstein, Jacquie Chirgwin, Alan S Coates

Breast Cancer Res Treat· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT.
Olivia Pagani, Prudence A Francis, Gini F Fleming, Barbara A Walley, Giuseppe Viale, Alan S Coates

J Clin Oncol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Karin Ribi, Weixiu Luo, Marco Colleoni, Per Karlsson, Jacquie Chirgwin, Alan S Coates

Br J Cancer· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence.
Fabio Conforti, Laura Pala, Eleonora Pagan, Giuseppe Viale, Vincenzo Bagnardi, Alan S Coates

Breast Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
Karin Ribi, Weixiu Luo, Marco Colleoni, Per Karlsson, Jacquie Chirgwin, Alan S Coates

Br J Cancer· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neoadjuvant Degarelix Versus Triptorelin in Premenopausal Patients Who Receive Letrozole for Locally Advanced Endocrine-Responsive Breast Cancer: A Randomized Phase II Trial.
Silvia Dellapasqua, Kathryn P Gray, Elisabetta Munzone, Daniela Rubino, Lorenzo Gianni, Alan S Coates

J Clin Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
Thomas Ruhstaller, Anita Giobbie-Hurder, Marco Colleoni, Maj-Britt Jensen, Bent Ejlertsen, Alan S Coates

J Clin Oncol· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial.
Viviana Galimberti, Bernard F Cole, Giuseppe Viale, Paolo Veronesi, Elisa Vicini, Alan S Coates

Lancet Oncol· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
Elisabetta Munzone, Kathryn P Gray, Caterina Fumagalli, Elena Guerini-Rocco, István Láng, Alan S Coates

Breast Cancer Res Treat· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
Prudence A Francis, Olivia Pagani, Gini F Fleming, Barbara A Walley, Marco Colleoni, Alan S Coates

N Engl J Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial.
Irene L Wapnir, Karen N Price, Stewart J Anderson, André Robidoux, Miguel Martín, Alan S Coates

J Clin Oncol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial.
Marco Colleoni, Weixiu Luo, Per Karlsson, Jacquie Chirgwin, Stefan Aebi, Alan S Coates

Lancet Oncol· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
When do patient reported quality of life indicators become prognostic in breast cancer?
Chee Khoon Lee, Malcolm Hudson, John Simes, Karin Ribi, Jürg Bernhard, Alan S Coates

Health Qual Life Outcomes· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials.
Poornima Saha, Meredith M Regan, Olivia Pagani, Prudence A Francis, Barbara A Walley, Alan S Coates

J Clin Oncol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Follow-Up of the Intergroup Exemestane Study.
James P Morden, Isabel Alvarez, Gianfilippo Bertelli, Alan S Coates, Robert Coleman

J Clin Oncol· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cholesterol, Cholesterol-Lowering Medication Use, and Breast Cancer Outcome in the BIG 1-98 Study.
Signe Borgquist, Anita Giobbie-Hurder, Thomas P Ahern, Judy E Garber, Marco Colleoni, Alan S Coates

J Clin Oncol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial.
Irene L Wapnir, Shari Gelber, Stewart J Anderson, Eleftherios P Mamounas, André Robidoux, Alan S Coates

Ann Surg Oncol· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.
Harriet Johansson, Kathryn P Gray, Olivia Pagani, Meredith M Regan, Giuseppe Viale, Alan S Coates

Breast Cancer Res· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Timing of Radiation Therapy and Chemotherapy After Breast-Conserving Surgery for Node-Positive Breast Cancer: Long-Term Results From International Breast Cancer Study Group Trials VI and VII.
Per Karlsson, Bernard F Cole, Karen N Price, Richard D Gelber, Alan S Coates

Int J Radiat Oncol Biol Phys· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis